166 related articles for article (PubMed ID: 16181105)
1. Increased pulmonary heme oxygenase-1 and delta-aminolevulinate synthase expression in monocrotaline-induced pulmonary hypertension.
Iwasaki T; Takahashi T; Shimizu H; Ohmori E; Morimoto T; Kajiya M; Takeuchi M; Morita K; Akagi R; Kajiya F
Curr Neurovasc Res; 2005 Apr; 2(2):133-9. PubMed ID: 16181105
[TBL] [Abstract][Full Text] [Related]
2. Hemin treatment abrogates monocrotaline-induced pulmonary hypertension.
Shimzu K; Takahashi T; Iwasaki T; Shimizu H; Inoue K; Morimatsu H; Omori E; Matsumi M; Akagi R; Morita K
Med Chem; 2008 Nov; 4(6):572-6. PubMed ID: 18991742
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1-dependent pathway.
Zhang WH; Zhang YJ; Liu CP; Yu BX; Lu WX
Exp Lung Res; 2011 Oct; 37(8):492-9. PubMed ID: 21867382
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload.
Goto J; Ishikawa K; Kawamura K; Watanabe Y; Matumoto H; Sugawara D; Maruyama Y
Antioxid Redox Signal; 2002 Aug; 4(4):563-8. PubMed ID: 12230867
[TBL] [Abstract][Full Text] [Related]
5. [Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by up-regulating heme oxygenase-1 expression].
Zhang Y; Wang D; Zhu T; Li C
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):151-4. PubMed ID: 22381746
[TBL] [Abstract][Full Text] [Related]
6. Protective role of heme oxygenase-1 induction in carbon tetrachloride-induced hepatotoxicity.
Nakahira K; Takahashi T; Shimizu H; Maeshima K; Uehara K; Fujii H; Nakatsuka H; Yokoyama M; Akagi R; Morita K
Biochem Pharmacol; 2003 Sep; 66(6):1091-105. PubMed ID: 12963497
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific delta-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome.
Suzuki T; Takahashi T; Yamasaki A; Fujiwara T; Hirakawa M; Akagi R
Biochem Pharmacol; 2000 Jul; 60(2):275-83. PubMed ID: 10825473
[TBL] [Abstract][Full Text] [Related]
8. Increased heme oxygenase-1 and decreased delta-aminolevulinate synthase expression in the liver of patients with acute liver failure.
Fujii H; Takahashi T; Matsumi M; Kaku R; Shimizu H; Yokoyama M; Ohmori E; Yagi T; Sadamori H; Tanaka N; Akagi R; Morita K
Int J Mol Med; 2004 Dec; 14(6):1001-5. PubMed ID: 15547665
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in Bach1 expression in the kidney of rhabdomyolysis-associated acute kidney injury.
Yamaoka M; Shimizu H; Takahashi T; Omori E; Morimatsu H
PLoS One; 2017; 12(7):e0180934. PubMed ID: 28704479
[TBL] [Abstract][Full Text] [Related]
10. Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
Lee FY; Lu HI; Zhen YY; Leu S; Chen YL; Tsai TH; Chung SY; Chua S; Sheu JJ; Hsu SY; Chang HW; Sun CK; Yip HK
Eur J Pharm Sci; 2013 Nov; 50(3-4):372-84. PubMed ID: 23954457
[TBL] [Abstract][Full Text] [Related]
11. Regulation of kininogen gene expression and localization in the lung after monocrotaline-induced pulmonary hypertension in rats.
Chao J; Simson JA; Chung P; Chen LM; Chao L
Proc Soc Exp Biol Med; 1993 Jun; 203(2):243-50. PubMed ID: 8502664
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
13. Effects of simvastatin on pulmonary C-fiber sensitivity in rats with monocrotaline-induced pulmonary hypertension.
Hsu HH; Ruan T; Ko WJ; Hsu JY; Chen JS; Lee YC; Lai IR; Chen CF
J Heart Lung Transplant; 2011 Mar; 30(3):332-40. PubMed ID: 21075647
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
[TBL] [Abstract][Full Text] [Related]
16. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
[TBL] [Abstract][Full Text] [Related]
17. AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-κB pathway in rats.
Hu Y; Feng Z; Feng W; Hu T; Guan H; Mao Y
Biomed Pharmacother; 2019 Jan; 109():1319-1326. PubMed ID: 30551382
[TBL] [Abstract][Full Text] [Related]
18. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
20. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
